The study "contributes to efforts that may one day redefine the diagnostic system in psychiatry, which may have practical clinical implications," commented Dr. Tiffany Herlands.
Researchers at Columbia University found that non-medical cannabis use—including frequent or problematic use—is significantly more common in adults with pain than in those without pain.
Dr. Mark Olfson said looking at large groups, instead of homing in on specific individuals, allows for other factors to affect the suicide rates — even if the study tried to control for some of them.
Researchers at Columbia University used magnetic resonance imaging (MRI) to understand brain structural alterations in children and adolescents with OCD that predict psychotherapy treatment response.
A new study from researchers at Columbia University Vagelos College of Physicians and Surgeons suggests that prenatal exposure to flame retardants may increase the risk of reading problems.
"We were surprised to learn that there has been a larger decrease in opioid prescribing to adults with more rather than less severe pain," Dr. Mark Olfson said.
In an accompanying editorial, Dr. Joshua T. Kantrowitz explained how the future role of lumateperone could be crucial in treating schizophrenia patients.
The Center for OCD and Related Disorders, directed by Dr. Blair Simpson, focuses on how to better understand, and ultimately treat, obsessive-compulsive disorder and related problems.
“The efficacy and safety profile of CAPLYTA approved by the FDA, offers healthcare providers an important new option for treating people living with schizophrenia,” said Dr. Jeffrey A. Lieberman.